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Abstract 
 
Background. Kidney stone disease is common in industrialized countries. Recently, it 
has attracted growing attention, because of its significant association with adverse 
renal outcomes, including end stage renal disease. Calcium-containing kidney stones 
are frequent with high recurrence rates. While hypercalciuria is a well-known risk factor, 
restricted intake of animal protein and sodium, combined with normal dietary calcium, 
has been shown to be more effective in stone prevention compared with a low-calcium 
diet. Notably, the average sodium intake in Switzerland is twice as high as the WHO 
recommendation, while the intake of milk and dairy products is low.  
Methods. We retrospectively analyzed Swiss recurrent kidney stone formers (rKSF) 
to test the impact of a low-sodium in combination with a low-calcium diet on the urinary 
risk profile. In patients with recurrent calcium oxalate containing stones, we 
investigated both, the consequence of a low-sodium diet on urinary volume and 
calcium excretion, and the influence of a low-sodium low-calcium diet on urinary 
oxalate excretion. 
Results. Of the 169 patients with CaOx stones, 49 presented with hypercalciuria at 
baseline. The diet resulted in a highly significant reduction in 24-h urinary sodium and 
calcium excretion: from 201 ± 89 at baseline to 128 ± 88 mmol/d for sodium (p<0.0001), 
and from 5.67 ± 3.01 to 4.06 ± 2.46 mmol/d (p<0.0001) for calcium, respectively. Urine 
volume remained unchanged. Notably, no increase in oxalate excretion occurred on 
the restricted diet (0.39 ± 0.26 vs 0.39 ± 0.19 mmol/d, p=0.277). Calculated Psf 
(probability of stone formation) values were only predictive for the risk of calcium 
phosphate stones.  
Conclusion. A diet low in sodium and calcium in recurrent calcium oxalate stone 
formers resulted in a significant reduction of urinary calcium excretion, but no change 
in urine volume. In this population with apparently low intake of dairy products, calcium 
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restriction does not necessarily result in increased urinary oxalate excretion. However, 
based on previous studies, we recommend a normal dietary calcium intake to avoid a 
potential increase in urinary oxalate excretion and unfavorable effects on bone 
metabolism in hypercalciuric KSFs. 
Trial registration. Approved by the institutional review board.  
 
Background 
Kidney stones are common in industrialized countries with an increasing prevalence 
over the last several decades [1, 2]. Calcium-containing stones are the most frequent 
stone type and almost 40% of patients experience a second stone episode within three 
years of the first [3]. Importantly, several studies have described a significant 
association between kidney stones and adverse renal outcomes, including end stage 
renal disease (ESRD) [4-8], as well as an increased risk for coronary heart disease [9]. 
Thus, metaphylaxis plays a crucial role in treatment and has been shown to prevent 
stone recurrence and potentially chronic kidney disease [10], and may help to 
decrease the huge economic burden of stone disease, including expensive and 
repetitive urological interventions, large amounts of sick pay, and days lost from work, 
etc. [11]. While hypercalciuria is a well-known risk factor for kidney stone formation, 
restricted intake of animal protein and salt, combined with a normal calcium intake, has 
been shown to be more effective in the prevention of stone recurrence when compared 
with a low-calcium diet [12]. In particular, recurrent kidney stone formers (rKSFs) are 
recommended to reduce their salt intake, since high salt consumption itself is 
associated with hypercalciuria [13]. According to the last Swiss nutrition report, the 
average salt intake in Switzerland (10.6 g/d in males and 8.1 g/d in females) is 
approximately twice as high as the WHO recommendations (< 5 g/d). On the other 
hand, surprisingly, too little milk and dairy products are consumed (Sixth Swiss 
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Nutrition Report 2012, www.bag.admin.ch), which could result in increased dietary 
oxalate absorption and urinary excretion. According to published data [12], a high 
sodium diet in combination with low dairy products and consequently low calcium 
intake in the Swiss population should lead overall to an increased dietary risk for kidney 
stone formation. However, other studies have shown a positive correlation between 
sodium excretion and 24-hour urine volume, suggesting that sodium restriction may 
decrease thirst and thus fluid intake, resulting in an increased risk for kidney stone 
formation [14-16]. 
In our clinic, rKSFs were subjected to metabolic evaluation according to a standard 
protocol, including a first 24-hour urine collection under normal diet, followed by a 
second 24-hour urine collection after a seven-day low sodium and low calcium diet. In 
this study, we wanted to analyze the effect of a low sodium in combination with a low 
calcium diet on the urinary risk profile of recurrent calcium oxalate kidney stone 
formers. In particular, we wanted to determine both, the impact of a low sodium diet on 
urinary volume and calcium excretion, and the influence of a low calcium diet on urinary 
oxalate excretion.  
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Methods 
Study population 
Between February 2007 and July 2011, 154 male and 61 female patients who were 
referred to our stone clinic for recurrent kidney stone disease were included in this 
retrospective analysis. There were no exclusion criteria. For the analysis of the impact 
of the low calcium and low sodium diet on the urinary risk profile we only included 
patients with calcium oxalate containing stones (n = 169). The institutional review 
board of the University Hospital Zurich (Zentrum für klinische Forschung und Lehre) 
approved data collection and analyses. 
At the first visit a detailed laboratory workup was performed, including blood and 24-
hour urine chemistry. After the first workup, patients undertook a calcium- and sodium-
reduced diet for seven days. The diet is routinely performed in our stone clinic to 
assess to which extent calciuria – one of the major risk factors of calcium oxalate 
stones - can be influenced by diet. On the last day of the diet we performed a second 
blood and 24-hour urine analysis. Using a standardized protocol prepared by a 
dietician, the treating physician explained the diet to each patient. Patients were 
counselled to avoid any food products or beverages high in sodium and discouraged 
from adding table salt during the preparation of meals. In addition to sodium restriction, 
patients were instructed to avoid dairy products and mineral waters rich in calcium or 
calcium supplements during the seven-day period. In the case of full adherence, the 
diet provides an approximate daily intake of 346 mg calcium (range 211 – 480 mg or 
5.3 – 12 mmol/d) and 1.25 g sodium (range 0.7 - 1.8 g or 31.8 - 78.8 mmol/d). 
We used the Psf (probability of stone formation) algorithm for predicting stone risk and 
stone type that has been developed and validated by Robertson and colleagues [17, 
18]. This calculation is based on a relative risk comparison of the key and routinely 
measured urinary stone risk and protective factors - urine volume, pH, calcium, oxalate, 
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uric acid, citrate and magnesium - in controls and stone formers, and gives a probability 
score (typically in controls <0.5 and in stone formers >0.5) of stone formation and likely 
stone composition in the absence of any available stone analysis result. For the Psf 
calculations presented we combined patients with known stone composition in the 
above cohort (n = 192) with rKSF and known stone composition from a second cohort 
(n = 138) that was investigated in a separate study (Manuscript in preparation). 
 
Biochemical analyses 
All laboratory analyses were performed at the Institute of Clinical Chemistry of the 
University Hospital Zurich. At baseline, 24-hour urine was collected without addition of 
preservative agents or oil (native). The second 24-hour urine collection was performed 
by adding thymol (1g per 3l urine container, Hänseler AG, Herisau, Switzerland) to 
inhibit bacterial growth and metabolization of urea to ammonia. In addition, mineral oil 
(75ml per 3l urine container, Hänseler AG, Herisau, Switzerland) was added to the 
second container when collection was started to allow for adequate pH measurement. 
Stone composition was determined by X-Ray diffractometry. 
 
Probability of stone formation (Psf) 
As already described, the Psf value was calculated to test for predictability of the risk 
of formation: calcium oxalate, calcium phosphate, uric acid, or a combination of these 
stone types, and to assess whether the Psf might be influenced by the short-term 
dietary manipulation. For each patient with known stone composition, the Psf for stone 
formation was calculated for the following stone types: calcium oxalate, mixed calcium 
oxalate/phosphate, uric acid, mixed uric acid/calcium oxalate, and calcium phosphate; 
the closer the Psf value is to 1, the more likely it is that a patient will form a stone of 
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8 
that type. Patients with Psf values below 0.5 are deemed less likely to form stones and 
have a risk equivalent to that of non-stone formers. 
 
Definitions 
Hypercalciuria was defined as urinary calcium excretion > 6.25 mmol/day for female 
and > 7.5 mmol/day for male subjects. Hyperoxaluria was defined as urinary oxalate 
excretion > 0.5 mmol/day. Hyperuricosuria was defined as 24-hour uric acid excretion 
> 4.5 mmol/day for women and > 4.8 mmol/day for men, and hypocitraturia as urinary 
citrate excretion < 1.50 mmol/day. A stone was considered to be pure if it consisted of 
≥ 95% of a single component.  
 
Statistical analyses 
Demographic and clinical characteristics were documented for individual patients at 
the first visit. All statistical analyses were performed using SPSS Version 20.0 
statistical package (SPSS Inc, USA) and Graphpad Prism Version 5 (GraphPad 
Software, Inc., USA). For paired analyses of normally distributed variables Student's 
paired t-test (Shapiro-Wilks; p> 0.05) and for non-parametric data Wilcoxon test were 
used, respectively. Continuous variables were reported as means ± SD (standard 
deviation). Categorical variables were compared using the chi square test. 
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Results 
Characteristics of study population 
Patient demographics are shown in Table 1. Two hundred and fifteen patients were 
included in our study (mean age 47.1 ± 13.9 years), 154 were male and 61 females. 
As expected, pure calcium oxalate calculi were the most frequent stone type (42 %). 
The second most common stone type was of mixed type, consisting of calcium oxalate 
combined with calcium phosphate or urate (38 %). Calcium phosphate stones were 
significantly more common in female patients (8 % vs. 2 %, p= 0.043), whereas pure 
calcium oxalate stones were more frequent in men (46% vs. 31 %, p=0.048). Notably, 
stone composition was unknown in only 11 % of all patients (Table 1b). Figure 1a 
demonstrates urinary risk factors in all patients, while Figure 1b displays risk factors 
of only patients with stones that were consisting entirely or partially of calcium oxalate. 
In our cohort, hypocitraturia was the most prevalent risk factor, followed by 
hypercalciuria (Figure 1a). Notably, hypocitraturia was significantly more common in 
females (p = 0.013) (Figure 1a, b), whereas hyperoxaluria and hyperuricosuria 
appeared to be more prevalent in male stone formers; however, the difference was not 
statistically significant. Hypercalciuria was slightly more common in patients with 
calcium oxalate containing stones (Figure 1b) when compared with the whole cohort 
(Figure 1a). Figure 1 (c, d) displays the prevalence of metabolic abnormalities in 
males and females. The majority of patients had one single metabolic abnormality 
(48%), whereas 18% had two, and 4% had a combination of three of them. In 
approximately 30% of all patients no urinary abnormality (hypercalciuria, 
hyperoxaluria, hyperuricosuria or hypocitraturia) was detectable (Figure 1c). There 
was no significant difference in the number of urinary metabolic abnormalities between 
genders in the whole cohort (Figure 1c) or in the subgroup of patients with calcium 
oxalate containing stones (Figure 1d). 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
10 
 
Table 1a. Baseline characteristics of total cohort (standard deviation) 
Characteristic Male (n = 154) Female (n = 61) Total (n = 215) 
Age, yr 46.9 (13.0) 47.6 (16.0) 47.1 (13.9) 
Weight , kg 83.0 (14.3) 69.7 (16) 79.2 (16.0) 
Body mass index, kg/m2  27.0 (3.9) 26.3 (6.2) 26.8 (4.6) 
Number of stone episodes 3.4 (2.3) 2.8 (1.6) 3.2 (2.1) 
 
Table 1b. Stone composition by gender 
Stone type Male (n = 154) Female (n = 61) Total (n = 215) 
Calciumoxalate n (%) 71 (46) 19 (31) 90 (42) 
Apatite n (%) 3 (2) 5 (8) 8 (4) 
Uric acid n (%) 6 (4) 1 (2) 7 (3) 
Mixed n (%) 57 (37) 25 (41) 82 (38) 
Others n (%) 3 (2) 2 (4) 5 (2) 
Unknown n (%) 14 (9) 9 (14) 23 (11) 
 
 “Mixed” stones include Calciumoxalate with Apatite, Uric acid, Struvite, Brushite, or 
Whitlockite. 
 
Effect of sodium and calcium reduced diet on urinary risk profile of patients with 
calcium oxalate stones 
One hundred and sixty-nine patients (125 males and 44 females) had calcium oxalate 
containing stones. Dietary reduction of sodium and calcium resulted in a significant 
reduction in 24-h urinary excretion of both sodium and calcium: 201 ± 89 at baseline 
vs. 128 ± 88 mmol/d for sodium (p<0.001) and 5.67 ± 3.01 vs. 4.06 ± 2.46 mmol/d for 
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calcium (p<0.001) (Table 2). There was also a significant correlation between urinary 
sodium and calcium excretion (Figure 2a, b). Despite an average 36% reduction of 
sodium excretion as a reflection of reduced intake, 24-h urine volume did not fall after 
seven days of diet (2170 ± 904 vs. 2145 ± 724 ml/24h) (Figure 2c). In parallel with 
sodium and calcium, 24-h phosphate excretion significantly decreased after diet, 
probably reflecting the reduced intake of dairy and protein products (28.53 ± 10.52 vs. 
24.04 ± 9.68 mmol/24h, p< 0.001). In addition, an increase in plasma PTH was noted 
at the end of the low sodium low calcium diet probably in response to the decrease in 
calcium intake. Surprisingly, despite reduced calcium intake during the dietary period, 
no change in urinary oxalate excretion was found (0.39 ± 0.26 vs. 0.39 ± 0.19 mmol/d, 
p=0.277). Supplementary table 1 shows the effect of the low-sodium low-calcium diet 
on blood and urine parameters according to gender. Although male calcium oxalate 
stone formers showed a larger reduction in urinary sodium excretion after diet when 
compared with women, no decrease in urine volume could be observed at the end of 
the intervention. Furthermore, changes in blood and urine parameters were mostly 
similar in both male and female patients. We repeated the analysis after excluding the 
twelve patients with secondary causes of kidney stones. The results did not differ 
significantly in this subgroup (Supplementary table 2).  
 
Table 2: Plasma and urine chemistry in patients with calcium oxalate containing kidney 
stones at baseline and after seven days on low-calcium low-sodium diet 
Blood parameters () Baseline (SD) Diet (SD) 
Creatinine in umol/l 86.3 (22.0) 88.3 (21.8)* 
Sodium in mmol/l 141.4 (2.3) 141.6 (1.9)ns 
Potassium in mmol/l 3.9 (0.3) 4.0 (0.4)*** 
Magnesium in mmol/l 0.82 (0.07) 0.84 (0.08)*** 
Bicarbonate in mmol/l 26.4 (2.5) 26.8 (2.7)* 
Uric acid in mmol/l 331.4 (82.2) 351.1 (93.0)*** 
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Urea in mmol/l 5.6 (1.9) 5.3 (2.0)** 
Chloride in mmol/l 104.9 (2.7) 104.6 (2.8)ns 
Calcium in mmol/l 2.3 (0.1) 2.3 (0.1)ns 
Phosphate in mmol/l 1.0 (0.2) 0.9 (0.2)ns 
iPTH in pg/l 47.4 (20.0) 49.2 (18.8)* 
1,25-(OH)2-Vitamin D3 in 
ng/ml 
52.0 (16.1) nd 
   
Urine parameters (SD)   
Volume in ml 2170 (904) 2145 (724)ns 
Urinary pH 6.3 (0.6) 6.4 (0.6)ns 
Sodium in mmol/d 200.7 (89.0) 128.3 (87.6)*** 
Potassium in mmol/d 65.8 (31.9) 60.7 (28.7)* 
Chloride in mmol/d 195.0 (81.4) 128.0 (78.6)*** 
Calcium in mmol/d 5.7 (3.0) 4.1 (2.5)*** 
Magnesium in mmol/d 4.1 (1.7) 4.0 (1.8)ns 
Phosphate in mmol/d 28.5 (10.5) 24.0 (9.7)*** 
Urea in mmol/d 416.3 (151.3) 366.7 (139.8)*** 
Creatinine in mmol/d 14.0 (4.4) 13.8 (4.7)ns 
Uric acid in mmol/d 3.5 (1.3) 3.3 (1.2)ns 
Glucose in mmol/d 4.0 (26.5) 2.3 (8.9)ns 
Citrate in mmol/d 2.4 (1.6) 2.5 (1.5)ns 
Oxalate in mmol/d 0.39 (0.26) 0.39 (0.19)ns 
Ammonium in mmol/d nd 42.2 (77.7) 
 
nd = not determined; ns = non significant = p > 0.05, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 
0.001; SD = standard deviation 
 
Adherence to low sodium and low calcium diet 
As described above, prescription of the 7-day-diet consisted of a standardized written 
protocol that was prepared by a dietitian and subsequently transmitted to the patient 
by the responsible physician. To minimize the effect of poor adherence to the diet on 
the results of urinary oxalate excretion and urine volume we performed a separate 
analysis in calcium oxalate stone formers after exclusion of all patients whose 24-h 
urinary sodium did not decrease while on diet. One hundred and thirty-one patients 
with calcium oxalate containing stones were included in this sub-analysis. On average, 
24-h urinary sodium excretion decreased by 51% (212 ± 84 vs 104 ± 66 mmol/24h, p< 
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0.001) in this group. In parallel, urinary calcium excretion declined from 6.07 ± 2.91 to 
3.77 ± 2.19 mmol/24h (38% reduction; p < 0.001). Again, no significant difference was 
observed for urine volume (2248 ± 836 vs. 2145± 724 ml/24h; p = 0.081) or oxalate 
excretion in the 24h urine collections (0.39 ± 0.26 before vs. 0.38 ± 0.17 mmol/24h 
after diet, p = 0.607) (Figure 3). However, 24-h excretion of phosphate (29.72 ± 10.60 
vs. 22.42 ± 9.10 mmol/24h (p < 0.001)) and urea (428 ± 144 vs. 346 ± 132 mmol/d 
(p<0.001) were significantly reduced, indicating reduced dairy protein consumption. 
Interestingly, urinary magnesium excretion, considered as a protective factor, 
significantly decreased in patients that complied with the diet (4.3 ± 1.6 vs. 3.8 ± 1.7 
mmol/24h; p = 0.0001). Again, the results did not change significantly when we 
excluded the nine patients with secondary causes of nephrolithiasis (Supplementary 
table 3). 
 
Effect of the sodium and calcium reduced diet on urinary risk profile of patients 
with hypercalciuria 
Of 169 patients with calcium oxalate containing stones, 49 (29%) were hypercalciuric 
at baseline. After the 7-day combined low sodium and low calcium intervention, 12 
patients remained hypercalciuric (9.91 ± 1.77 vs. 8.96 ± 1.99 mmol/24h) (data were 
missing from 2 patients). In these patients, no significant reduction of urinary sodium 
excretion was detectable (243 ± 79 vs. 186 ± 123 mmol/24h; p = 0.084), suggesting 
non-adherence to the prescribed dietary sodium restriction. In addition, phosphate 
excretion was not different (32.8 ± 9.9 vs. 29.7 ± 9.9 mmol/24h; p = 0.388), indicating 
poor adherence to calcium reduction during the diet. In contrast, 35 of the 
hypercalciuric patients demonstrated a significant decrease in urinary sodium (235 ± 
88 vs. 112 ± 83 mmol/24h; p < 0.0001), and calcium excretion (9.24 ± 1.87 pre vs. 4.60 
± 1.44 mmol/24h post diet; p<0.001), respectively. In parallel, urinary phosphate 
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excretion was significantly lower after the low sodium and low calcium dietary 
intervention (33.0 ± 8.4 vs. 25.0 ± 7.4 mmol/24h; p < 0.0001). In contrast to previously 
published data, no increase in urinary oxalate excretion was observed (0.41 ± 0.14 vs. 
0.41 ± 0.14, p = 0.437). In summary, in 75% of the patients with calcium oxalate 
nephrolithiasis and hypercalciuria, a short-term dietary intervention by reducing sodium 
and calcium in the diet resulted in a significant decrease in urinary calcium without a 
significant increase in urinary oxalate excretion. The above described results were not 
significantly different, when we excluded the three patients with secondary causes of 
nephrolithiasis (data not shown). 
 
Probability of stone formation (Psf) 
We used the Psf score [17] to assess the predictability of stone composition in an 
extended cohort and to assess the effect of the 7-day low sodium and low calcium diet 
on Psf. In a cohort of 330 patients, including 215 patients described above (200 with 
CaOx, 22 with CaP, 13 with uric acid, 89 with mixed CaOx/CaP, and 6 with mixed uric 
acid/CaOx stones) the calculated Psf score from the baseline 24h-urine parameters 
was only predictive with medium accuracy for CaP stones (Table 3a). In 215 patients 
that were subjected to the diet, the Psf for a CaP stone was significantly lower on diet, 
suggesting a decreased risk of developing calcium phosphate stones after dietary 
sodium and calcium restriction (Table 3b). However, in our patient population, the 
calculated Psf score according to other stone types did not correlate with stone 
composition.  
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Discussion 
Hypercalciuria is the most frequent metabolic abnormality in individuals with calcium-
containing kidney stones and can be found in up to 50% of these subjects [19, 20]. It 
can be caused by several conditions, including systemic diseases such as primary 
hyperparathyroidism or sarcoidosis, and if no underlying cause can be identified, it is 
considered idiopathic. Several mechanisms have been discussed in the pathogenesis 
of idiopathic hypercalciuria, such as increased intestinal calcium absorption and 
increased urinary calcium loss due to decreased proximal tubular reabsorption, and/or 
loss from bone [21, 22]. However, rather than a disease in itself, it probably reflects the 
upper end of the normal distribution of urinary calcium excretion in a population [23]. 
Nonetheless, the level of hypercalciuria is positively associated with the risk of 
developing calcium kidney stones [24]. In addition to an increase in fluid intake, which 
has been demonstrated to decrease the risk of recurrent kidney stones [25], reduction 
of sodium intake is another key strategy, since the excretion of sodium in urine strongly 
correlates with the magnitude of calciuria. Therefore, reduced sodium intake results in 
a reduction in urinary calcium excretion [26-31]. In our study, we could demonstrate 
that a short-term combined low sodium and low calcium dietary intervention also 
resulted in a significant reduction in urinary calcium excretion. In addition, other dietary 
factors with an effect on urinary calcium excretion such as the acid load from animal 
protein or ammonium chloride strongly increase urinary calcium excretion, whereas 
sodium bicarbonate administration mildly decreases calciuria [32]. Thus, the significant 
decline in calciuria in our patients may result from the combined effect of dietary 
sodium and calcium restriction, as well as from reduced consumption of animal 
proteins (dairy products) indicated by reduced phosphorus and urea excretion. 
Interestingly, citrate excretion and urine pH were unchanged before and after the diet, 
suggesting that the overall reduction of dietary protein intake was modest. However, 
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since dietary calcium restriction has previously been shown to reduce calciuria only 
modestly [32], we assume that the impact of the short-term diet on calciuria was 
predominantly due to sodium restriction. 
Hyperoxaluria is another important risk factor for calcium kidney stones [24]. 
Interestingly, the impact of dietary oxalate on urinary oxalate excretion and 
development of kidney stones appears to be small [33, 34], while the degree of enteric 
oxalate absorption seems to be more critical [35]. The latter is determined by different 
factors, including a significant intra- and inter-individual variability, and depends on the 
bioavailability of oxalate that can be affected by dietary intake of calcium or magnesium 
[35, 36]. In a randomized controlled trial by Borghi et al., a diet low in sodium and 
animal protein reduced stone recurrence rates after five years compared with a low 
calcium diet in male recurrent kidney stone formers with idiopathic hypercalciuria [12]. 
In both diet groups, urinary calcium excretion decreased by approximately 50%, similar 
to our hypercalciuric patients with calcium oxalate stones who complied with the low 
sodium diet. However, in the Borghi study, urinary oxalate excretion significantly 
increased in patients on a low calcium (10 mmol/day = 0.4 g/d) diet compared with 
patients on a combined low protein (93 g/day), low sodium (50 mmol/day) and normal 
calcium diet (30 mmol/day = 1.2 g/d), and remained high during the five years of follow-
up. The increase in urinary oxalate was thought to be secondary to increased enteric 
absorption of oxalate when dietary calcium is low, and this was proposed as the 
underlying mechanism for the higher stone recurrence rate in this patient group. 
Previous interventional and observational studies have also described an inverse 
relationship between calcium (and animal protein) intake and risk of kidney stones [37-
39]. These data have been confirmed by an interventional study which demonstrated 
that an increase in calcium intake led to a decrease in oxaluria within one week [40]. 
Thus, a low calcium diet is no longer recommended for the prevention of calcium 
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oxalate stone recurrence [41]. Interestingly, the patients with calcium oxalate stones in 
our study did not show any increase in urinary oxalate excretion on a one-week low 
sodium and low calcium diet. There may be several reasons for this finding. First, a 
physician explained the diet to patients in addition to a written brochure, but there were 
no fixed or standardized meals and so the dietary calcium reduction might not have 
been sufficiently low to affect oxalate absorption and cause hyperoxaluria. The finding 
that plasma PTH increased significantly at the end of the diet supports, however, that 
dietary calcium intake was reduced. In addition, after exclusion of patients with 
unchanged sodium excretion - indicative of non-adherence to the diet - oxalate 
excretion was still not higher after seven days on the low sodium and low calcium diet. 
Yet, even the adherent patients in our study probably did not lower their daily calcium 
intake to such low levels (150 -250 mg/d) as in the above studies describing an 
increase in oxaluria upon dietary calcium reduction [37, 39].  Second, we cannot 
exclude that patients also reduced their oxalate intake while on the diet. However, as 
described earlier, the impact of dietary oxalate on oxaluria seems to be quite small [33] 
even though this assumption has been challenged by oxalate loading studies. Yet, 
oxalate loading studies should be interpreted cautiously, because of methodological 
problems regarding the reliability of the assays that have been used to measure 
oxalate, and it is also unclear whether the oxalate used in the oral loading studies has 
a similar bioavailability to oxalate in food [33, 35, 42-44]. Finally, by assuming that due 
to a low intake of dairy products (Sixth Swiss Nutrition Report 2012; www.bag-
admin.ch) the average calcium intake in the Swiss population may already be low, a 
further reduction of calcium consumption may not have had any additional effect on 
enteric oxalate absorption. In a study by von Unruh and others, the authors found an 
inverse relationship between calcium intake and intestinal oxalate absorption [44]. A 
reduction of oral calcium intake by 70 mg/day was associated with a 1% increase in 
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oxalate absorption. Consequently, if baseline calcium intake is already low (as 
assumed in our population), and absolute calcium reduction during the diet is only 
modest (e.g. from 700 to 400 mg/d), the effect of the dietary calcium reduction in our 
study on urinary oxalate excretion may be small [42]. In comparison with the studies 
by Borghi et al. [12] and Nakada et al. [40], our patients were also different with respect 
to other factors such as gender, ethnic background, and normal diet.  
Magnesium excretion is positively associated with oxaluria, while decreases in sodium 
excretion or a reduced intake of animal protein appear to have no impact on 
hyperoxaluria [33]. The 7-day dietary intervention in our study led to a slight, but 
significant decrease in urinary magnesium excretion that may also explain the absence 
of any increase in oxalate excretion under the low sodium and low calcium diet.  
Another important finding in our study is that even a significant reduction in sodium 
intake was not enough to affect thirst and to lower urine volume, since a low urine 
volume would be expected to increase stone risk. However, we cannot exclude that 
individuals coincidentally increased their fluid intake, e.g., following advice from their 
urologist, general practitioner, peers or recommendations found on the internet.  
Lastly, in this particular Swiss population, the Psf score to predict stone risk and type 
was of limited value. This might be explained by genetic or environmental differences 
between the Swiss cohort and the population studied from which the algorithm was 
derived. Additionally, we performed the metabolic workup in most patients according 
to international guidelines weeks or months after the last stone episode or intervention, 
and stone analysis. Therefore, it is likely that a significant proportion of the patients 
had already changed their diet due to recommendations of the urologist or advice from 
other sources. 
Conclusion 
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 Our data demonstrate that reducing sodium consumption in rKSFs in combination with 
a low calcium diet results in a significant reduction in urinary calcium excretion, but not 
a reduction in urine volume. Furthermore, calcium restriction in patients with low dietary 
calcium intake does not necessarily result in increased urinary oxalate excretion. Thus, 
a diet low in calcium, as currently in the wider Swiss population, seems to be safe in 
terms of the risk of stone recurrence.  
To summarize, further prospective studies are required to test if the diet of the Swiss 
population is associated with a higher prevalence of hyperoxaluria and/or calcium 
oxalate kidney stone formation. However, based on previous studies, we believe that 
to avoid an increase in urinary oxalate excretion and unfavorable effects on bone 
metabolism, assessment and correction of low calcium intake in hypercalciuric KSFs 
is important and a normal dietary intake of calcium should be recommended.  
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CaP  calcium phosphate 
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Table 3: a) Probability of stone formation (Psf) in an extended cohort of 330 patients (median, interquartile range); b) Influence of low- 
salt low-calcium diet on Psf in the cohort of 215 patients with dietary intervention. 
Stone type Delta (95%, CI) p-value 
CaOx -0.06 (-0.10,-0.01) 0.02 
CaP -0.09 (-0.13,-0.05) <0.001 
Uric acid (UA) 0.02 (0.00,0.05) 0.06 
UA/CaOx 0.02 (-0.01,-0.05) 0.11 
CaOx/CaP -0.06 (-0.11,-0.01) 0.03 
 
CaOx = calcium oxalate, CaP = calcium phosphate, UA = uric acid, CaOx/CaP = mixed calcium oxalate and calcium phosphate, 
UA/CaOx mixed uric acid and calcium oxalate, CI = confidence interval. 
 
Factor CaOx CaP UA CaOx/CaP UA/CaOx p-value  
N 200 22 13 89 6   
PSF CaOx, 0.25 (0.07, 0.68) 0.38 (0.10, 0.50) 0.03 (0.01, 0.21) 0.21 (0.08, 0.67) 0.13 (0.02, 0.17) 0.039  
PSF CaP 0.5 (0.24, 0.72) 0.87 (0.75, 0.95) 0.23 (0.17, 0.32) 0.68 (0.45, 0.88) 0.28 (0.00, 0.49) <0.001  
PSF UA 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.68  
PSF CaOx/CaP, 0.33 (0.07, 0.73) 0.59 (0.24, 0.76) 0.10 (0.04, 0.32) 0.49 (0.12, 0.78) 0.08 (0.00, 0.16) 0.025  
PSF UA/CaOx, 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.73  
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Figure legends 
Figure 1: Frequency (a, b) and number (c, d) of metabolic risk factors in the whole 
cohort (a, c; n = 215) and in patients with calcium oxalate containing stones (b, d; n = 
169) according to gender. The incidence of hypocitraturia at baseline was significantly 
higher in female patients (* p < 0.05.), whereas the other risk factors did not show a 
significant difference. 
Figure 2: Correlation between 24-h urinary sodium and 24-h urinary calcium excretion 
pre- (a) and post-diet (b) and (c) between Δ 24-h urinary sodium and Δ 24-h urinary 
volume excretion in 215 recurrent kidney stone formers. 
Figure 3: 24 h excretion of sodium (a), urine volume (b), calcium (c), oxalate (d), 
phosphate (e) and urea (f) in calcium oxalate stone formers with successful dietary 
sodium restriction (mean (SD); ns = not significant = p > 0.05, *p ≤ 0.05, ** p ≤ 0.01, 
*** p ≤ 0.001; SD = standard deviation). 
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